These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 11055464)

  • 1. The problem of hypertension in the elderly.
    Hedner T
    Blood Press Suppl; 2000; 2():4-6. PubMed ID: 11055464
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Problem of Hypertension in the Elderly.
    Hedner T
    Blood Press; 2000; 9(sup2):4-6. PubMed ID: 28425789
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cardiovascular events in elderly patients with isolated systolic hypertension. A subgroup analysis of treatment strategies in STOP-Hypertension-2.
    Ekbom T; Linjer E; Hedner T; Lanke J; De Faire U; Wester PO; Dahlöf B; Scherstén B
    Blood Press; 2004; 13(3):137-41. PubMed ID: 15223721
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Results of the STOP-Hypertension-2 trial.
    Hansson L
    Blood Press Suppl; 2000; 2():17-20. PubMed ID: 11055467
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The outcome of STOP-Hypertension-2 in relation to the 1999 WHO/ISH hypertension guidelines.
    Lindholm LH
    Blood Press Suppl; 2000; 2():21-4. PubMed ID: 11055468
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Isolated systolic hypertension in the elderly].
    Gareri P; Olivo M; Ciotti D; Ritacco AR; Rotundo A; Berardelli M; Mattace R
    Minerva Med; 2001 Dec; 92(6):453-72. PubMed ID: 11740433
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The 2004 Canadian recommendations for the management of hypertension: Part II--Therapy.
    Khan NA; McAlister FA; Campbell NR; Feldman RD; Rabkin S; Mahon J; Lewanczuk R; Zarnke KB; Hemmelgarn B; Lebel M; Levine M; Herbert C;
    Can J Cardiol; 2004 Jan; 20(1):41-54. PubMed ID: 14968142
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Current recommendations for the treatment of hypertension: are they still valid?
    Moser M
    J Hypertens Suppl; 2002 Feb; 20(1):S3-10. PubMed ID: 11996197
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Systolic hypertension in the elderly: addressing an unmet need.
    Duprez DA
    Am J Med; 2008 Mar; 121(3):179-184.e3. PubMed ID: 18328297
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term safety of antihypertensive therapy.
    Grossman E; Messerli FH
    Prog Cardiovasc Dis; 2006; 49(1):16-25. PubMed ID: 16867847
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Large therapeutic studies in elderly patients with hypertension.
    Orozco-Valero M
    J Hum Hypertens; 2002 Mar; 16 Suppl 1():S38-43. PubMed ID: 11986892
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Target blood pressure in elderly hypertensive patients: how low should you go?
    Zanchetti A
    Blood Press Suppl; 2000; 2():7-11. PubMed ID: 11055465
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Shifting trends in the pharmacologic treatment of hypertension in a Nigerian tertiary hospital: a real-world evaluation of the efficacy, safety, rationality and pharmaco-economics of old and newer antihypertensive drugs.
    Adigun AQ; Ishola DA; Akintomide AO; Ajayi AA
    J Hum Hypertens; 2003 Apr; 17(4):277-85. PubMed ID: 12714973
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rationale and design of the avoiding cardiovascular events through combination therapy in patients living with systolic hypertension (ACCOMPLISH) trial: the first randomized controlled trial to compare the clinical outcome effects of first-line combination therapies in hypertension.
    Jamerson KA; Bakris GL; Wun CC; Dahlöf B; Lefkowitz M; Manfreda S; Pitt B; Velazquez EJ; Weber MA
    Am J Hypertens; 2004 Sep; 17(9):793-801. PubMed ID: 15363822
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cost analysis of different pharmacological treatment strategies in elderly hypertensives.
    Linjer E; Hedner T; Jönsson B; Ekbom T; Lindholm LH; Dahlöf B; de Faire U; Scherstén B;
    Blood Press; 2005; 14(2):107-13. PubMed ID: 16036488
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Oral inhibitors of renin and their potential use as therapeutic agents in treating hypertension].
    Abassi Z; Armaly Z; Nakhoul F; Hoffman A
    Harefuah; 2008 Jun; 147(6):536-42, 573. PubMed ID: 18693632
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Aggressive blood pressure control and stroke prevention: role of calcium channel blockers.
    Papadopoulos DP; Papademetriou V
    J Hypertens; 2008 May; 26(5):844-52. PubMed ID: 18398322
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Optimal treatment of hypertension in the elderly: a Korean perspective.
    Kim KI; Cho YS; Choi DJ; Kim CH
    Geriatr Gerontol Int; 2008 Mar; 8(1):5-11. PubMed ID: 18713183
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Isolated systolic hypertension as risk factor. Also in this case lowering blood pressure makes sense].
    Offers E; Kolloch R
    MMW Fortschr Med; 2000 Nov; 142(47):26-8. PubMed ID: 11143775
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Are newer antihypertensive agents better than the older ones? Results of trials (CAPPP, STOP-2, NORDIL, INSIGHT and ALLHAT) with newer antihypertensive agents].
    Hildebrandt PR; Tuxen CD; Kjeldsen SE; Lund-Johansen P; Hansson L
    Ugeskr Laeger; 2001 Dec; 164(1):18-21. PubMed ID: 11810791
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.